IMCR vs RMD · rev $222.6M vs P/E 29, rev $5.65B
Immunocore Holdings Ltd (IMCR) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
IMCR currently screens at market cap $1.45B. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the IMCR and RMD stock pages for the full models.
Not investment advice.